During the recent session, Clover Health Investments, Corp. (NASDAQ:CLOV)’s traded shares were 1,893,975, with the beta value of the company hitting 0. At the last check, the stock’s price was $7.22, reflecting an intraday loss of -1.77% or -$0.13. The 52-week high for the CLOV share is $17.45, that puts it down -141.69% from that peak though still a striking +12.6% gain since the share price plummeted to a 52-week low of $6.31. The company’s market capitalization is $2.92 Billion, and the average intraday trading volume over the past 10 days was 4.71 Million shares, and the average trade volume was 16.58 Million shares over the past three months.
Clover Health Investments, Corp. (CLOV) received a consensus recommendation of Overweight from analysts. That translates to a mean rating of 2. CLOV has a Sell rating from none of the analyst(s) out of 4 analysts who have looked at this stock. 2 analyst(s) recommend to Hold the stock while none of them suggest Overweight, and 2 recommend a Buy rating for it. None of the analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -$0.84.
Clover Health Investments, Corp. (NASDAQ:CLOV): Trading Information
Clover Health Investments, Corp. (CLOV) registered a -1.77% downside in the last session and has traded in the red over the past 5 sessions. The stock spiked 7.65% in intraday trading to $7.84- this Tuesday, Apr 06, hitting a weekly high. The stock’s 5-day price performance is -4.24%, and it has moved by -1.5% in 30 days. Despite these dips, the overall price performance for the year is -56.83%. The short interest in Clover Health Investments, Corp. (NASDAQ:CLOV) is 29.62 Million shares and it means that shorts have 1.79 day(s) to cover.
The consensus price target of analysts on Wall Street is $13.25, which implies an increase of 83.52% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $10 and $15 respectively. As a result, CLOV is trading at a discount of 107.76% off the target high and 38.5% off the low.
Clover Health Investments, Corp. (CLOV) projections and forecasts
An analysis of the company’s performance over the past 5 years shows that the company’s earnings fell an estimated 0%. While earnings are projected to return 0% in 2021, the next five years will return 0% per annum.